5 completed. 5 Phase 1, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 5 |
| Phase 2 | 4 | Completed 4 |
Follow Fetal Alcohol Spectrum Disorders: new trials by email Literature Review of Fetal Alcohol Spectrum Disorders trials Research Report on Fetal Alcohol Spectrum Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Postnatal Choline Supplementation in Children With Prenatal Alcohol Exposure Choline bitartrate, Placebo for choline bitartrate - Fetal Alcohol Spectrum Disorders, Fetal Alcohol Syndrome | Phase 1 / Phase 2 | Completed | University of Minnesota | 60 | 2010-07-01 | 2016-12-19 |
| Assess the Effectiveness of Atomoxetine in Children With Fetal Alcohol Syndrome and ADD/ADHD Strattera, Placebo - Fetal Alcohol Syndrome, Attention Deficit Disorder With Hyperactivity (ADHD) | Phase 1 | Completed | University of Oklahoma | 38 | 2005-08-01 | 2017-04-10 |
| Neurocognitive Habilitation for Children With Fetal Alcohol Syndrome (FAS)/Alcohol-Related Neurodevelopmental Disorder (ARND) neurocognitive habilitation - Fetal Alcohol Syndrome, Alcohol-related Neurodevelopmental Disorder | Phase 1 / Phase 2 | Completed | Centers for Disease Control and Prevention | 100 | 2002-01-01 | 2011-03-24 |
| Fetal Alcohol Syndrome: Socio-Cognitive Habilitation math, behavior regulation - Fetal Alcohol Syndrome | Phase 1 / Phase 2 | Completed | Centers for Disease Control and Prevention | 100 | 2001-10-01 | 2008-04-28 |
| Fetal Alcohol Syndrome/ARND Research Consortion Parent-child Interaction Therapy (PCIT) - Fetal Alcohol Syndrome | Phase 1 / Phase 2 | Completed | Centers for Disease Control and Prevention | 100 | 2001-10-01 | 2008-04-28 |
Attention Deficit Disorder with Hyperactivity (1)
Alcohol-Induced Disorders (5) · Alcohol-Related Disorders (5) · Chemically-Induced Disorders (5) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (5) · Female Urogenital Diseases and Pregnancy Complications (5) · Fetal Diseases (5) · Pregnancy Complications (5) · Substance-Related Disorders (5) · Urogenital Diseases (5) · Attention Deficit and Disruptive Behavior Disorders (1) · Mental Disorders (1) · Neurodevelopmental Disorders (1)
Atomoxetine Hydrochloride (1) · Choline (1)
Centers for Disease Control and Prevention (3) · University of Minnesota (1) · University of Oklahoma (1)
United States (5)
Ira Chasnoff, MD (1) · Jeffrey R Wozniak, Ph.D. (1) · John Mulvihill, MD (1) · Laura J McGuinn, PhD (1) · Michael Georgieff, M.D. (1)
PMID 20375733, PMID 22251828, PMID 26447156, PMID 32164522, PMID 33876196, PMID 36526961, PMID 39956364
R21AA019580 (1)